Table 3 Cross-classification of seropositivity to C. trachomatis and other sexually transmitted infections and risk of ovarian cancer: results from the NHS and NHSII

From: Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies

 

Control, n

All cases

Invasive EOC

  

Case, n

RRa

95% CI

Case, n

RRa

95% CI

C. trachomatis (CT) and M. genitalium (MG)

 CT− and MG−

291

263

Ref.

203

Ref.

 CT+ and MG−

37

57

1.89

1.11–3.20

43

1.79

1.08–2.97

 CT− and MG+

6

8

1.12

0.34–3.74

5

0.93

0.26–3.31

 CT+ and MG+

3

9

4.38

1.03–18.56

6

5.74

1.23–26.72

CT and herpes simplex virus, type 2 (HSV2)

 CT− and HSV2−

276

253

Ref.

197

Ref.

 CT+and HSV2−

32

46

1.85

1.06–3.24

34

1.67

0.97–2.87

 CT− and HSV2+

21

18

1.01

0.50–2.03

11

0.73

0.33–1.62

 CT+ and HSV2+

8

20

2.90

1.14–7.37

15

3.26

1.25–8.51

CT and HSV and MG

 CT− and HSV2− and MG−

272

245

Ref.

192

Ref.

 CT+ and HSV2− and MG−

30

41

1.77

0.98–3.18

32

1.64

0.94–2.85

 CT− and (HSV2+ or MG+)

25

26

1.19

0.63–2.23

16

0.90

0.45–1.81

 CT+ and (HSV2+ or MG+)

10

25

3.04

1.29–7.21

17

3.25

1.33–7.96

CT and HSV and MG and human papillomavirus (HPV) 16 E6, HPV18 E6+E7, or HPV45 E6+E7

 Negative for all

270

237

Ref.

186

Ref.

 CT+ only

29

41

1.88

1.03–3.42

32

1.73

0.99–3.03

 MG+, HSV2+ or HPV+ only

27

34

1.34

0.80–2.24

22

1.19

0.64–2.24

 CT+ and any other infection

11

25

2.74

1.20–6.27

17

3.01

1.26–7.18

  1. CT and HPV combination not evaluated, 0 cases and 3 controls positive for both infections
  2. CI confidence interval, EOC epithelial ovarian cancer, NHS Nurses’ Health Study, RR relative risk
  3. aConditional logistic regression models for all cases; all other results are from unconditional logistic regression models additionally controlling for matching factors (year of birth (±1 year), menopausal status at diagnosis (premenopausal, postmenopausal, unknown), and factors at one or both blood draws: menopausal status (premenopausal, postmenopausal, unknown), month of collection (±1 month), time of day (±2 h), fasting status (>8, ≤8 h), and postmenopausal hormone use (yes/no). Premenopausal NHSII cases and controls additionally matched on luteal day at blood collection (date of next menstrual cycle minus date of blood draw, ±1 day)). All adjusted models adjusted for: parity (nulliparous, 1 pregnancy, 2 pregnancies, 3 pregnancies, 4 + pregnancies), oral contraceptive use (never, <1 year, 1–5 years, 5+ years), tubal ligation (yes, no), marital status (never, married/domestic partnership/living with partner, divorced/separated, widowed), and weight change between ages 18 years and blood collection (kg, continuous)